In Silico Evaluation of Binding of 2-Deoxy-D-Glucose with Mpro of nCoV to Combat COVID-19
COVID-19 has threatened the existence of humanity andthis infection occurs due to SARS-CoV-2 or novel coronavirus, was first reported in Wuhan, China. Therefore, there is a need to find a promising drug to cure the people suffering from the infection. The second wave of this viral infection was shak...
Saved in:
Main Authors: | Anirudh Pratap Singh Raman (Author), Kamlesh Kumari (Author), Pallavi Jain (Author), Vijay Kumar Vishvakarma (Author), Ajay Kumar (Author), Neha Kaushik (Author), Eun Ha Choi (Author), Nagendra Kumar Kaushik (Author), Prashant Singh (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An understanding of coronavirus and exploring the molecular dynamics simulations to find promising candidates against the Mpro of nCoV to combat the COVID-19: A systematic review
by: Madhur Babu Singh, et al.
Published: (2022) -
2-Deoxy-D-Glucose: A Novel Pharmacological Agent for Killing Hypoxic Tumor Cells, Oxygen Dependence-Lowering in Covid-19, and Other Pharmacological Activities
by: Raman Singh, et al.
Published: (2023) -
In silico investigation of HCV and RNA synthesis inhibitor antibiotic drugs as potential inhibitors of SARS‑CoV‑2 main protease (Mpro)
by: Merusomayajula V. Kishore, et al.
Published: (2024) -
In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
by: Baby Krishnaprasad, et al.
Published: (2020) -
Plants in our combating strategies against Mycobacterium tuberculosis: progress made and obstacles met
by: Vivek Kumar Gupta, et al.
Published: (2017)